Introduction Prostate cancer (PCa) remains one of the most common malignancies in men globally, presenting a substantial public health challenge due to its highly variable clinical behavior and outcomes (1). Although many cases follow an indolent course, a clinically significant subset—characterized by high-grade disease, molecular alterations, or advanced staging—is associated with elevated risks of disease progression, therapeutic resistance, and mortality (2, 3).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Danyan
Contact Danyan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack